The strength of this study is that we used pre-vaccinated samples, reducing potential vaccine-induced confounders, and we determined the functional activity of MPO in COVID-19 subjects compared to previous studies that reported only quantitative levels3,24. The gene discussed is MPO; the disease is COVID-19.